BERNINI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 15.098
AS - Asia 14.973
EU - Europa 9.370
SA - Sud America 1.996
AF - Africa 717
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 42.184
Nazione #
US - Stati Uniti d'America 14.683
SG - Singapore 5.568
CN - Cina 4.020
VN - Vietnam 2.231
IE - Irlanda 1.638
BR - Brasile 1.559
FI - Finlandia 1.293
IT - Italia 1.253
HK - Hong Kong 1.198
DE - Germania 1.197
SE - Svezia 1.162
UA - Ucraina 914
ZA - Sudafrica 559
FR - Francia 555
TR - Turchia 551
NL - Olanda 453
BD - Bangladesh 446
CA - Canada 272
GB - Regno Unito 264
RU - Federazione Russa 206
IN - India 187
AR - Argentina 181
AT - Austria 106
IQ - Iraq 104
JP - Giappone 96
KR - Corea 78
MX - Messico 75
ID - Indonesia 74
EC - Ecuador 66
PL - Polonia 61
PH - Filippine 59
CO - Colombia 55
BE - Belgio 52
ES - Italia 49
CZ - Repubblica Ceca 48
VE - Venezuela 47
PK - Pakistan 44
TH - Thailandia 43
UZ - Uzbekistan 38
PY - Paraguay 31
TW - Taiwan 31
MA - Marocco 30
SA - Arabia Saudita 25
EG - Egitto 24
CL - Cile 20
KE - Kenya 20
JO - Giordania 19
AE - Emirati Arabi Uniti 18
CI - Costa d'Avorio 18
AL - Albania 17
IL - Israele 17
EU - Europa 15
MY - Malesia 15
KZ - Kazakistan 14
LT - Lituania 14
PE - Perù 14
DZ - Algeria 13
IR - Iran 13
TN - Tunisia 13
UY - Uruguay 13
OM - Oman 12
RO - Romania 12
AU - Australia 11
ET - Etiopia 10
NP - Nepal 10
HN - Honduras 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
BG - Bulgaria 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
JM - Giamaica 8
PA - Panama 8
BO - Bolivia 7
LB - Libano 7
BY - Bielorussia 6
KG - Kirghizistan 6
KW - Kuwait 6
QA - Qatar 6
RS - Serbia 6
SY - Repubblica araba siriana 6
BB - Barbados 5
CH - Svizzera 5
CR - Costa Rica 5
LU - Lussemburgo 5
MD - Moldavia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
PT - Portogallo 5
SN - Senegal 5
GR - Grecia 4
NG - Nigeria 4
AO - Angola 3
BH - Bahrain 3
CM - Camerun 3
CY - Cipro 3
DK - Danimarca 3
GE - Georgia 3
HR - Croazia 3
MK - Macedonia 3
Totale 42.127
Città #
Singapore 2.616
San Jose 1.690
Dublin 1.638
Chandler 1.551
Ashburn 1.361
Hong Kong 1.126
Jacksonville 1.117
Beijing 1.064
Santa Clara 905
Ho Chi Minh City 677
Dallas 621
Boardman 537
Johannesburg 525
Nanjing 508
Hanoi 505
Dearborn 498
Izmir 485
New York 426
Princeton 388
Ann Arbor 376
Lauterbourg 361
Parma 304
Los Angeles 284
Wilmington 260
Munich 240
San Mateo 234
Bremen 230
Hefei 180
Helsinki 179
Toronto 171
Shanghai 164
Shenyang 154
São Paulo 143
Nanchang 137
Hebei 134
Moscow 126
Council Bluffs 120
Kunming 118
Buffalo 117
Columbus 107
Seattle 100
Jinan 98
Haiphong 97
Des Moines 96
Tianjin 94
Vienna 91
Da Nang 85
Jiaxing 78
Chicago 74
Woodbridge 74
Grafing 73
Changsha 71
Milan 67
Guangzhou 63
Rome 62
Marseille 59
Norwalk 57
Seoul 55
Tokyo 55
Orem 52
Brussels 49
Houston 49
The Dalles 48
Warsaw 47
Zhengzhou 47
Hải Dương 46
Turku 44
Bologna 43
Brooklyn 43
Frankfurt am Main 40
Biên Hòa 39
Montreal 39
Pune 38
Rio de Janeiro 38
Baghdad 37
Belo Horizonte 37
Hangzhou 35
Chennai 33
Tashkent 33
Atlanta 32
Jakarta 32
Denver 30
San Francisco 30
Fremont 29
Brno 28
Brasília 27
Phoenix 27
Guayaquil 26
Ninh Bình 26
Nuremberg 26
Taiyuan 26
Curitiba 24
London 24
Can Tho 23
Stockholm 23
Mexico City 22
Düsseldorf 21
Manchester 21
Modena 21
Quito 21
Totale 25.202
Nome #
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 346
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 283
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 249
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 236
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 235
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 234
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 218
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 215
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 208
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 201
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 200
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 182
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 181
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 177
Antiatherogenic effects of ellagic acid and urolithins in vitro 177
Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study 174
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 169
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 169
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum 168
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 167
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 167
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 164
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 163
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 162
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 162
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 160
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 154
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 154
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 153
Cholesterol efflux and reverse cholesterol transport 153
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 153
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 152
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 151
CHARACTERIZATION OF THREE KINDRED WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 150
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 150
A NOVEL MUTATION IN CETP GENE AS A CAUSE OF CETP DEFICIENCY IN A CAUCASIAN KINDRED 149
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 149
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 149
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 148
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 147
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 147
Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. 147
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 146
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 146
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 146
New MDR1 inhibitors for overcoming multidrug resistance 146
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 145
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 145
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 145
Role of Apolipoprotein E in cellular cholesterol efflux 144
The natural compound berberine positively affects macrophage functions involved in atherogenesis 144
5,6-diphenylpyridazine derivatives as acyl-Coacholesterol acyltransferase inhibitors 143
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 143
6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells. 143
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 142
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 142
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 142
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 142
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 142
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 141
Cholesterol efflux potential of sera from subjects with LCAT deficiency 140
Probucol inhibits ABCA1-mediated cellular lipids efflux 139
CHOLESTEROL EFFLUX AND CHOLESTEROL LOADING CAPACITY OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 139
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 138
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 138
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 138
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 137
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 137
EFFECT OF VITAMIN D REPLACEMENT ON SERUM LIPOPROTEIN FUNCTIONALITY IN HEALTHY PRE-MENOPAUSAL WOMEN 137
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 137
Natural anti-endothelial cell antibodies (AECA) 135
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 135
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 134
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 134
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 133
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 133
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 133
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 132
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 132
Cholesterol efflux capacity and arterial stiffness: data from the brisighella heart study 130
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 130
ANTIATHEROSCLEROTIC EFFECTS OF A NEW COMBINATION OF BERBERINE, MONACOLIN K AND MORUS ALBA: IMPROVEMENT OF HDL FUNCTION 130
New mechanisms for steroid pro-atherogenic action: up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracelluar cholesterol stores. 129
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 129
Attivita’ del probucolo nell’inibire l’efflusso lipidico cellulare ABCA1 mediato 128
A novel homozigous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 128
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 128
An w-3 polyunsaturated fatty acid concentrate increases plasma HDL2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 127
A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE 127
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability and telomere length in healthy octogenarians 127
Effects of a new combination of Berberine, Monacolin k and Morus Alba on lipid profile and HDL functions in healty subjects: a pilot study 127
Lacidipine modulates the secretion of matrix metalloproteinase-9 by human macrophages 126
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 126
IN VIVO ACUTE SYSTEMIC INFLAMMATION, INDEPENDENTLY ON THE ETIOLOGY, AFFECTS HDL CHOLESTEROL EFFLUX CAPACITY 126
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 126
The c-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phopspholipid and cholesterol efflux 125
ATTIVITA’ IPOLIPIDEMIZZANTE DEL NUTRACEUTICO OLEACTIV® NEL MODELLO DEL CRICETO GOLDEN SYRIAN 125
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model 125
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. 125
Natural anti-endothelial cell antibodies (AECA) 124
Totale 15.409
Categoria #
all - tutte 152.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/20221.594 46 17 13 58 36 95 185 211 92 151 81 609
2022/20236.014 702 447 306 439 738 672 54 332 2.042 42 177 63
2023/20242.168 126 244 66 73 151 603 122 157 49 82 157 338
2024/20257.487 137 454 533 428 762 711 229 336 966 732 582 1.617
2025/202616.123 1.262 1.575 1.738 1.283 2.356 806 2.129 573 2.098 1.181 684 438
Totale 42.750